Biogen's Scangos joins Agilent board

Chutes and Ladders

Welcome to this week's Chutes and Ladders, our roundup of hirings and firings throughout the industry. Please send the good word--or the bad--from your shop to Michael Gibney (email | Twitter) or Emily Mullin (email | Twitter) and we will feature it here at the end of each week.

Biogen's Scangos joins Agilent board

George Scangos, CEO and director of Biogen Idec ($BIIB), has been appointed to the biotech IT firm Agilent's ($A) board of directors and will join the board in September. Scangos replaces Dr. David Lawrence, who is retiring after 13 years on the Agilent board. Release

Agilent
Biogen Idec CEO George Scangos has joined Agilent's board of directors.


Novira Therapeutics
Christian Schade will be the new CEO.


Biotech

Novira Therapeutics named Christian Schade as its new CEO. Release

Deloitte has named Sarah Thomas as director, Deloitte Services LP and director of research for the Deloitte Center for Health Solutions. Release

Dr. Aiping Young is leaving her position as president and chief operating officer of Lorus Therapeutics. Release

Alan Vicory Jr. joined the scientific advisory board at Tauriga Sciences. Release

Inergetics appointed Dr. Michelle Sexton as a member of its scientific and medical advisory board. Release

Joseph Chalil joined Provectus Biopharmaceuticals' strategic advisory board. Release

Mirna Therapeutics appointed Casi DeYoung as the company's chief business officer. Release

Halloran Consulting group hired Sonna Patel-Raman, who formerly worked with the FDA as branch chief. Release

Clarus Therapeutics appointed John Gargiulo as the company's chief operating officer. Release

Tamara Joseph joined InVivo Therapeutics as general counsel and chief compliance officer. Release

Pharma

Takeda Pharmaceuticals has appointed Giles Platford head of commercial operations. Item

Apricus Biosciences ($APRI) has appointed Neil Morton as vice president of business development. Release

Rich Pharmaceuticals appointed Dr. McCoy Moretz to its medical advisory board. Release

QPharma named Matt Crusan its director of DEA compliance and services. Release

Mystic Pharmaceuticals named Gerald Cagle and Dr. Grady Rylander members of its scientific advisory board. Release

Paul Berns assumed the role of CEO at Anacor Pharmaceuticals, where he is chairman of the board of directors. Release

CRO

> CiToxLAB has brought on John Kapeghian as senior director of toxicology in North America. Release

Drug Delivery

Unilife ($UNIS) has named Dennis Pyers, vice president and controller of Unilife since 2010, interim CFO. Release

Suggested Articles

Preclinical-stage biotech Abpro Therapeutics wants to trial its two lead candidates for HER2-positive cancers and diabetic macular edema in 2019.

After a rough patch in 2017, the stars seem to be realigning for French CAR-T expert Cellectis, which just closed a $164 million U.S. public offering.

Investment firm Frazier Healthcare Partners has closed its 11th fund—worth $780 million—that will help established companies accelerate their growth.